Company / Revenue
Q32 Bio Inc. Revenue History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
-
FY2025
5-year range
-$6.7M / $34.0M
FY2021-FY2025
Trend
+100.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $3M to $0 over the past 2 years.
Revenue over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, revenue increased 100.0% year-over-year.
- Peak revenue was recorded in FY2022.
- Lowest revenue in the period was in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -2.77 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0 | +100.0% |
| FY2024 | -$6.7M | -307.3% |
| FY2023 | $3.2M | -90.6% |
| FY2022 | $34.0M | +1157.3% |
| FY2021 | $2.7M | +62.2% |
| FY2020 | $1.7M | -68.7% |
| FY2019 | $5.3M | +44.5% |
| FY2018 | $3.7M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026